Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Andreas Stahl(Universitätsmedizin Greifswald), Domenico Lepore(Università Cattolica del Sacro Cuore), Alistair R. Fielder(City, University of London), Brian W. Fleck(University of Edinburgh), James D. Reynolds(Jacobs Institute), Michael F. Chiang(Oregon Health & Science University), Jun Li(Novartis (Switzerland)), Melissa Liew(Novartis (Switzerland)), Rainer Maier(Novartis (Switzerland)), Qi Zhu(Novartis (China)), Neil Marlow(University College Hospital)
The Lancet
September 12, 2019
Cited by 425Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis